Primary tabs
Export 23 results:
Filters: Author is Nicolas Willemarck
Beheer van biologisch besmet afval afkomstig van activiteiten van ingeperkt gebruik van genetisch gemodificeerde en/of pathogene organismen: Richtlijnen en aanbevelingen.,
, 12/2021, Belgium, Brussels, p.29, (2021)
Environmental Risk Assessment of Recombinant Viral Vector Vaccines against SARS-Cov-2,
, Vaccines, Jan-05-2021, Volume 9, Issue 5, (2021)
Opinion: Airtightness for Decontamination by Fumigation of High-Containment Laboratories,
, Applied Biosafety, 2019-08-27, (2019)
Biosafety in microbiology teaching laboratories,
, 16/10/2018, Charleston, South Carolina , (2018)
A Framework for the Risk Assessment and Management of Gene Drive Technology in Contained Use,
, Applied Biosafety, May-03-2018, Volume 23, Issue 1, Number 31, (2018)
Monitoring of Laboratory-Acquired Infections,
, Jan 2018, Issue CGM 2018-01, Bilthoven, The Netherlands, p.96, (2018)
Airtightness in Belgian high biocontainment facilities,
, 1/6/2016, Number 14, Brussels, p.14, (2016)
Airtightness in high containment facilities in Belgium,
, Annual meeting of the European Enforcement Project on Contained Use and Deliberate Release of GMOs, 27/5/2016, Issue EEP, NA, (2016)
Online tool: notification requirements for occupational bio-incidents in Belgium,
, VMx-BBP studiedag "Collaboration and integration of Environment, Biosafety and Health & Safety aspects", 13/10/2016, Issue VMx en BBP, NA, (2016)
Bio-incident notification as a tool to enhance biosafety,
, 1 18th Annual Conference of the European Biosafety Association, 22/4/2015, Issue EBSA, NA, (2015)
Laboratory-acquired infections in Belgium (2007-2012): an online survey,
, 1/2/2015, Number 49, Brussels, p.49, (2015)
Risk assessment for contained use of GMOs ,
, 5th World Congress on Biotechnology, 25/6/2014, Issue OMICS Group, (2014)
Environmental risk assessment of clinical trials involving modified vaccinia virus Ankara (MVA)-based vectors.,
, Curr Gene Ther, 2013 Dec, Volume 13, Issue 6, p.413-20, (2013)
Laboratoriuminfecites in Vlaanderen: "Incidenten en accidenten: voorkomen en remedïeren",
, Seminarie Bioveilighied UGent, 21/5/2013, Issue UGent, NA, (2013)
Laboratoriuminfecties in Vlaanderen (2007-2012) Een online bevraging,
, Seminar WIV-ISP / ToVo, 17/4/2013, Issue WIV-ISP and ToVo (Toezicht Volksgezondheid - Flemish Public Health Monitoring Department), NA, (2013)
Laboratory Acquired Infections in Belgium,
, 56 th Annual Biological Safety Conference, ABSA, 23/10/2013, Issue American Biological Safety Association (ABSA), NA, (2013)
Laboratory-Acquired Infections in Belgium,
, Seminarie, 29/11/2013, Issue SCK/CEN, NA, (2013)
Biosafety in laboratory animal facilities,
, 0/0/2012, Volume WIV-ISP Scientific Report 2010-2011, Number 94, Brussels, p.3, (2012)
Synthetic Biology. Latest developments, biosafety considerations and regulatory challenges,
, 0/0/2012, Number 43, Brussels, Belgium, p.43, (2012)
Biosafety in laboratory animal facilities. A practical approach.,
, 0/0/2011, Volume D/2011/2505/47, Number 44, Brussels, p.44, (2011)
Modaliteiten van validatie en controle van autoclaven in het kader van inactivatie van afval afkomstig van het ingeperkte gebruik van genetisch gemodificeerde micro-organismen en/of pathogenen,
, 0/0/2011, Volume D/2011/2505/46, Number 32, Brussels, p.32, (2011)
Modalités de validation et de contrôle des autoclaves dans le cadre de l'inactivation des déchets résultants d'utilisations confinées d'organismes génétiquement modifiés et/ou pathogènes,
, 0/0/2011, Volume D/2011/2505/39, Number 30, Brussels, p.30, (2011)